Clinical Trial Update: A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the safety and efficacy of nebulized tobramycin in patients with bronchiectasis. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Nebulized Tobramycin (tobramycin)

Snippet

Sponsor: Shandong University | Conditions: Bronchiectasis | Phase 4 | Status: UNKNOWN